Back

The Safety and Effectiveness of Ultra-low Temperature Cryoablation of Monomorphic VT in Patients with Ischemic and Non-Ischemic Cardiomyopathies

8 April 2024 (13:15 - 13:23)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Atul Verma

McGill University Health Centre, Montreal (Canada)

9 More presentations in this session

Presentation thumbnail
The Safety and Effectiveness of Ultra-low Temperature Cryoablation of Monomorphic VT in Patients with Ischemic and Non-Ischemic Cardiomyopathies - discussion
Doctor U. Tedrow (Boston, US)
Slides Video
Presentation thumbnail
First-in-Human Clinical Series of a Novel Conformable "Single-Shot" Pulsed Field Ablation Catheter for Pulmonary Vein Isolation
Professor V. Reddy (New York City, US)
Slides Video
Presentation thumbnail
First-in-Human Clinical Series of a Novel Conformable "Single-Shot" Pulsed Field Ablation Catheter for Pulmonary Vein Isolation - discussion
Professor J. Kalman (Melbourne, AU)
Slides Video
Presentation thumbnail
Ablation STrategies for Repeat PrOcedures in Patients with Atrial Fibrillation Recurrences despite Durable Pulmonary Vein Isolation
Doctor B. Schmidt (Frankfurt, DE)
Slides Video
Presentation thumbnail
Ablation STrategies for Repeat PrOcedures in Patients with Atrial Fibrillation Recurrences despite Durable Pulmonary Vein Isolation - discussion
Doctor D. Packer (Salt Lake City, US)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Science: ablation
Video

The Event

Event poster

EHRA 2024

8 April 2024 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Ultralow temperature cryoablation for ventricular arrythmias
thumbnail
Congress Presentation
The Safety and Effectiveness of Ultra-low Temperature Cryoablation of Monomorphic VT in Patients with Ischemic and Non-Ischemic Cardiomyopathies - discussion
thumbnail
Congress Presentation
Cryoablation of ventricular tachycardia using ultra-low temperature technology: acute success and insights from the post-interventional CMR

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources